HomeOpen Access NewsHealth & Social Care

Health & Social Care

Plastic-digesting superbug found in hospitals poses massive danger

A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.

Considering the role of personality for healthy ageing

Dr Mathias Allemand and Dr Patrick L. Hill discuss the complex factors contributing to healthy ageing, and explore the ways in which personality traits can be considered as a component.

CureVac vaccine performs at 47% efficacy in latest trial

The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.

How are disparities in smoking highlighting the global issue of health inequality?

C3 Collaborating for Health is working to make it easier for everyone to make healthier choices, and here, we learn why this is particularly important for smokers.

COVID-19 in Africa: Where are we?

Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.

COVID vaccines to be mandatory for care home workers

The UK Government will make COVID vaccination mandatory for care home workers, with the possibility that NHS workers will also be required to get the jab.

Delta variant twice as likely to cause COVID hospitalisation

A Scottish study, published in The Lancet, found the Delta variant was twice as likely as the Alpha variant to cause COVID hospitalisation.

PCR Biosystems: Scaling up the production of critical reagents in a crisis

Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.

North Tees & Hartlepool NHS Foundation Trust partners with ReStart

North Tees & Hartlepool NHS Foundation Trust (NTHFT) partners with ReStart to deliver integration into the Great North Care Record.

Why is research vital for generating the essential knowledge to ensure healthy ageing?

Dr Marina Ezcurra, Lecturer in the Biology of Ageing at the University of Kent, stresses the importance of innovative research focussed on understanding the fundamental processes underlying ageing.

Study finds 37% of doctors wanted to quit before COVID-19

A new study by The University of Manchester found that 37% of GPs intended to quit direct patient care, even before the COVID-19 pandemic hit.

The evolution of care in a post-COVID world

Imogen Keane, Business Development Manager at Service Robotics Ltd, explores how the remote care revolution is helping to address loneliness for the most vulnerable in our communities.

Committee report finds NHS “burnout is widespread reality”

After months of COVID, the psychological impact on staff emerges as a shadow pandemic - today (8 June), a Health Select Committee report finds that NHS "burnout is widespread reality".

Study finds fatigue is more common in mild COVID cases

Scientists have found that neurological symptoms, like fatigue, are more common in people with mild COVID cases - as opposed to only in severe COVID cases.

The importance of good oral health

Dr Hanna Kinsella, Owner and Principal Dentist of Kiln Lane Dental, argues that good oral health is crucial for our overall health and wellbeing.

Scientists examine link between COVID pressures and suicidal feelings

A study by Swansea University, Cardiff University, and the NHS in Wales found that COVID lockdown stressors like social isolation, domestic abuse, and financial issues were clearly linked to suicidal feelings and actions.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders